[1] BOSE S, TARAFDER S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 2012;8(4):1401-1421.
[2] LEGEROS, ZAPANTA R. Calcium phosphate-based osteoinductive materials. Chem Rev. 2008;108(11):4742-4753.
[3] EBRAHIMI M, BOTELHO M, LU W, et al. Synthesis and characterization of biomimetic bioceramic nanoparticles with optimized physicochemical properties for bone tissue engineering. J Biomed Mater Res A. 2019; 107(8):1654-1666.
[4] BOHNER M, TADIER S, VAN GARDEREN N, et al. Synthesis of spherical calcium phosphate particles for dental and orthopedic applications. Biomatter. 2013;3(2):e25103.
[5] CAO X, WANG G, WANG K, et al. Organic phosphorous and calcium source induce the synthesis of yolk-shell structured microspheres of calcium phosphate with high-specific surface area: Application in hel adsorption. Nanoscale Res Lett. 2020;15(1):69.
[6] MAAZOUZ Y, RENTSCH I, LU B, et al. In vitro measurement of the chemical changes occurring within beta-tricalcium phosphate bone graft substitutes. Acta Biomater. 2020;102:440-457.
[7] MAURO VD, IAFISCO M, SALVARANI N, et al. Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of micrornas. Nanomedicine. 2016;11(8):891-906.
[8] DEGLI ESPOSTI L, CARELLA F, ADAMIANO A, et al. Calcium phosphate-based nanosystems for advanced targeted nanomedicine. Drug Dev Ind Pharm. 2018;44(8):1223-1238.
[9] 程映,余冰琼,刘艳红,等.用于细胞成像的溶酶体ph荧光探针研究进展[J].武汉大学学报(理学版),2018,64(4):283-294.
[10] HE Y, ZENG B, LIANG S, et al. Synthesis of ph-responsive biodegradable mesoporous silica-calcium phosphate hybrid nanoparticle as a high potential drug carrier. ACS Appl Mater Interfaces. 2017;9:44402-44409.
[11] DONG X, WANG Q, WU T, et al. Understanding adsorption-desorption dynamics of bmp-2 on hydroxyapatite (001) surface. Biophys J. 2007; 93(3):750-759.
[12] XIE G, SUN J, ZHONG G, et al. Hydroxyapatite nanoparticles as a controlled-release carrier of bmp-2: absorption and release kinetics in vitro. J Mater Sci Mater Med. 2010;21(6):1875-1880.
[13] BANIK M, BASU T. Calcium phosphate nanoparticles: A study of their synthesis, characterization and mode of interaction with salmon testis DNA. Dalton Trans. 2014;43(8):3244-3259.
[14] SOKOLOVA V, EPPLE M. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed Engl. 2008;47(8):1382-1395.
[15] RAO H, LU Z, LIU W, et al. The adsorption of bone-related proteins on calcium phosphate ceramic particles with different phase composition and its adsorption kinetics. Surf Interface Anal. 2016;48(10):1048-1055.
[16] ZHOU P, WU J, XIA Y, et al. Loading bmp-2 on nanostructured hydroxyapatite microspheres for rapid bone regeneration. Int J Nanomedicine. 2018;13:4083-4092.
[17] CHOPRA I. Tetracycline antibiotics : Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232-260.
[18] 张亚楠,严霞,孟增东. Zn、mg增强羟基磷灰石骨修复材料临床应用与机制:生物活性及成骨诱导的研究进展[J].中国组织工程研究,2020,24(4):606-611.
[19] LEE GH, MAKKAR P, PAUL K, et al. Development of bmp-2 immobilized polydopamine mediated multichannelled biphasic calcium phosphate granules for improved bone regeneration. Mater Lett. 2017;208:122-125.
[20] LEE GH, MAKKAR P, PAUL K, et al. Incorporation of bmp-2 loaded collagen conjugated bcp granules in calcium phosphate cement based injectable bone substitutes for improved bone regeneration. Mater Sci Eng C-Mater Biol Appl. 2017;77:713-724.
[21] WANG D, TABASSUM A, WU G, et al. Bone regeneration in critical-sized bone defect enhanced by introducing osteoinductivity to biphasic calcium phosphate granules. Clin Oral Implants Res. 2017;28(3):251-260.
[22] LI X, LIU M, CHEN F, et al. Design of hydroxyapatite bioceramics with micro-/nano-topographies to regulate the osteogenic activities of bone morphogenetic protein-2 and bone marrow stromal cells. Nanoscale. 2020;12(13):7284-7300.
[23] STEGEN S, VAN GASTEL N, CARMELIET G. Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone. 2015;70:19-27.
[24] SCHUMACHER M, REITHER L, THOMAS J, et al. Calcium phosphate bone cement/mesoporous bioactive glass composites for controlled growth factor delivery. Biomater Sci. 2017;5(3):578-588.
[25] MLLER-SIEGERT J, PARMENTIER J, LAQUERRIèRE P, et al. Physicochemical regulation of tgf and vegf delivery from mesoporous calcium phosphate bone substitutes. Nanomedicine. 2017;12(15):1835-1850.
[26] BEDELOGLU E, ERSANLI S, ARISAN V. Vascular endothelial growth factor and biphasic calcium phosphate in the endosseous healing of femoral defects: An experimental rat study. J Dent Sci. 2017;12(1):7-13.
[27] 付福建,郑周海,史晓红,等.双膦酸盐诱导破骨细胞凋亡的作用机理研究[J].基因组学与应用生物学,2019,38(10):4726-4731.
[28] GIGER EV, CASTAGNER B, LEROUX JC. Biomedical applications of bisphosphonates. J Control Release. 2013;167(2):175-188.
[29] BIGI A, BOANINI E. Calcium phosphates as delivery systems for bisphosphonates. J Funct Biomater. 2018;9(1):6.
[30] ROOHANI-ESFAHANI SI, ZREIQAT H. Nanoparticles: a promising new therapeutic platform for bone regeneration? Nanomedicine. 2017; 12(5):419-422.
[31] PAULO S, LARANJO M, ABRANTES AM, et al. Synthetic calcium phosphate ceramics as a potential treatment for bisphosphonate-related osteonecrosis of the jaw. Materials. 2019;12(11):1840.
[32] SUN R, AHLEN M, TAI CW, et al. Highly porous amorphous calcium phosphate for drug delivery and bio-medical applications. Nanomaterials . 2019;10(1):20.
[33] NEAMTU J, BUBULICA MV, ROTARU A, et al. Hydroxyapatite–alendronate composite systems for biocompatible materials. J Therm Anal Calorim. 2016;127(2):1567-1582.
[34] BOANINI E, GAZZANO M, RUBINI K, et al. Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure. Adv Mater. 2007;19(18):2499-2502.
[35] SPELLBERG B, LIPSKY BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54(3):393-407.
[36] LI HK, ROMBACH I, ZAMBELLAS R, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019;380(5): 425-436.
[37] TURON P, DEL VALLE L, ALEMáN C, et al. Biodegradable and biocompatible systems based on hydroxyapatite nanoparticles. Appl Sci. 2017;7(1):60.
[38] POPA CL, DENIAUD A, MICHAUD-SORET I, et al. Structural and biological assessment of zinc doped hydroxyapatite nanoparticles. J Nanomater. 2016;(1): 1-10.
[39] SHANMUGAM S, GOPAL B. Copper substituted hydroxyapatite and fluorapatite: Synthesis, characterization and antimicrobial properties. Ceramics International. 2014;40(10):15655-15662.
[40] POUNTOS I, GEORGOULI T, BIRD H, et al. The effect of antibiotics on bone healing: Current evidence. Expert Opin Drug Saf. 2011;10(6): 935-945.
[41] USKOKOVIC V. Mechanism of formation governs the mechanism of release of antibiotics from calcium phosphate nanopowders and cements in a drug-dependent manner. J Mater Chem B. 2019;7(25): 3982-3992.
[42] USKOKOVIC V, BATARNI SS, SCHWEICHER J, et al. Effect of calcium phosphate particle shape and size on their antibacterial and osteogenic activity in the delivery of antibiotics in vitro. ACS Appl Mater Interfaces. 2013;5(7):2422-2431.
[43] MADHUMATHI K, RUBAIYA Y, DOBLE M, et al. Antibacterial, anti-inflammatory, and bone-regenerative dual-drug-loaded calcium phosphate nanocarriers—in vitro and in vivo studies. Drug Deliv Transl Res. 2018;8(5):1066-1077.
[44] TSUKASAKI M, TAKAYANAGI H. Osteoimmunology: Evolving concepts in bone-immune interactions in health and disease. Nat Rev Immunol. 2019;19(10):626-642.
[45] 刘伟,宋慧,董鹏.骨免疫学研究进展[J].骨科临床与研究杂志, 2020,5(2):124-126.
[46] CHEN Z, KLEIN T, MURRAY RZ, et al. Osteoimmunomodulation for the development of advanced bone biomaterials. Materials Today. 2016; 19(6):304-321.
[47] WANG J, LIU D, GUO B, et al. Role of biphasic calcium phosphate ceramic-mediated secretion of signaling molecules by macrophages in migration and osteoblastic differentiation of mscs. Acta Biomater. 2017; 51:447-460.
[48] WANG M, CHEN F, WANG J, et al. Calcium phosphate altered the cytokine secretion of macrophages and influenced the homing of mesenchymal stem cells. J Mater Chem B. 2018;6(29):4765-4774.
[49] ZARINS J, PILMANE M, SIDHOMA E, et al. Immunohistochemical evaluation after sr-enriched biphasic ceramic implantation in rabbits femoral neck: Comparison of seven different bone conditions. J Mater Sci Mater Med. 2018;29(8):119.
[50] LANGE J, SAPOZHNIKOVA A, LU C, et al. Action of il-1beta during fracture healing. J Orthop Res. 2010;28(6):778-784.
[51] XU ZP, ZENG QH, LU GQ, et al. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci. 2006;61(3):1027-1040.
[52] TAI W. Chemical modulation of sirna lipophilicity for efficient delivery. Journal of Controlled Release. 2019;307:98-107.
[53] LIU J, LI L, ZHANG R, et al. Development of cap nanocomposites as photothermal actuators for doxorubicin delivery to enhance breast cancer treatment. J Mater Sci Technol. 2020. DOI: 10.1016/j.jmst.2020.02.029
[54] QADIR A, GAO Y, SURYAJI P, et al. Non-viral delivery system and targeted bone disease therapy. Int J Mol Sci. 2019;20(3):565.
[55] CHERNOUSOVA S, KLESING J, SOKLAKOVA N, et al. A genetically active nano-calcium phosphate paste for bone substitution, encoding the formation of bmp-7 and vegf-a. RSC Advances. 2013;3(28):11155.
[56] TENKUMO T, VANEGAS SAENZ JR, TAKADA Y, et al. Gene transfection of human mesenchymal stem cells with a nano-hydroxyapatite-collagen scaffold containing DNA-functionalized calcium phosphate nanoparticles. Genes Cells. 2016;21(7):682-695.
[57] KELLY DC, RAFTERY RM, CURTIN CM, et al. Scaffold-based delivery of nucleic acid therapeutics for enhanced bone and cartilage repair. J Orthop Res. 2019;37(8):1671-1680.
[58] PATEL S, ATHIRASALA A, MENEZES PP, et al. Messenger rna delivery for tissue engineering and regenerative medicine applications. Tissue Eng Part A. 2019;25(1-2):91-112.
[59] MENCIA CASTAÑO I, CURTIN CM, DUFFY GP, et al. Next generation bone tissue engineering: Non-viral mir-133a inhibition using collagen-nanohydroxyapatite scaffolds rapidly enhances osteogenesis. Sci Rep. 2016;6:27941.
[60] LEE JE, YIN Y, LIM S Y, et al. Enhanced transfection of human mesenchymal stem cells using a hyaluronic acid/calcium phosphate hybrid gene delivery system. Polymers (Basel). 2019;11(5):798.
|